Karyopharm Therapeutics Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of KPTI for the last quarter is 33.13 M USD, and it's 1.84% lower compared to the previous quarter. The net income of Q1 24 is -37.36 M USD.